Astrana Health Inc. (ASTH)
NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ASTH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.44B
- P/E (TTM)
- 26.76
- Forward P/E
- 8.30
- EPS (TTM)
- $1.08
- Dividend yield
- None
- 52-week range
- 18.08 – 51.60
- Day range
- 28.33 – 29.75
- Volume / Avg
- 440.98K / 377.18K
- Beta
- —
- Shares outstanding
- 49.67M
52-week range
ASTH stock today
Shares of Astrana Health (ASTH) finished higher on Nov 20 at $28.90, a gain of 0.77% or $0.22 per share, versus the S&P 500's 3.70% decline. At this level, ASTH sits in the middle of its 52-week range of $18.08 to $51.60: 44.0% below the high, set on Jul 2, 2026 and 59.8% above the low. ASTH is up 16.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 28.4%.
At 26.8x trailing earnings, Astrana Health trades above the peer-group median of 17.4x. Its forward P/E of 8.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Astrana Health
Company profileAstrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
- Sector
- Consumer Discretionary
- Industry
- Professional Services
- CEO
- Mr. Brandon K. Sim M.S.
- Headquarters
- Alhambra, CA
- Employees
- 3,000
- Website
- astranahealth.com
Financial highlights
Full financialsIn fiscal 2025, Astrana Health generated $3.18 billion in revenue, up 56.4% from fiscal 2024, its 9th consecutive year of revenue growth. Net income was $22.5 million (-47.9% year over year), for a net margin of 0.7% versus a median of 4.4% in the prior 5 years. Gross margin was 10.7% (down from 13.3%) and operating margin 2.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.91M |
| Growth | +56.39% | +46.72% | +21.19% | +47.84% | +12.62% |
| Net income | $22.49M | $43.15M | $60.72M | $45.17M | $68.92M |
| EPS (diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 |
Analyst forecast
ForecastConsensus (11 analysts)
strong_buy
Avg. price target
$51.89+79.55%
- Strong buy 2
- Buy 8
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.01 vs $0.44
- Surprise
- -97.73%
ASTH news
All ASTH news- Astrana Health (ASTH) Q3 2026 Earnings Call TranscriptNasdaq
- Astrana Health, Inc. Reports Third Quarter 2026 ResultsPR Newswire
- Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California SeniorsGlobeNewswireALHC, ASTH
- Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference CallPR Newswire
Astrana Health peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ICFIICF International Inc. | 77.56 | +1.45% | $1.39B | vs ASTH |
| AMNAMN Healthcare Services Inc | 35.68 | +3.87% | $1.38B | vs ASTH |
| EFOREverforth Inc. | 31.32 | +7.89% | $1.29B | vs ASTH |
| NSPInsperity Inc. | 48.38 | +2.33% | $1.84B | vs ASTH |
| KFRCKforce Inc. | 54.55 | +1.92% | $976.88M | vs ASTH |
| KELYBKelly Services Inc. Class B | 23.60 | -3.28% | $822.25M | vs ASTH |
| MANManpowerGroup | 43.95 | +0.64% | $2.04B | vs ASTH |
| ONTOnterris Inc. | 21.69 | -7.11% | $762.40M | vs ASTH |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Astrana Health stock FAQ
What is Astrana Health's stock price today?
ASTH last traded at $28.90 as of Nov 20, 4:00 PM EST, up 0.77% on the day. Prices are delayed at least 15 minutes.
Does Astrana Health pay a dividend?
No. Astrana Health does not currently pay a regular cash dividend.
What is ASTH's P/E ratio?
ASTH trades at a trailing P/E ratio of 26.76 and a forward P/E of 8.30, compared with a median of 17.4 for its closest peers.
Who is Astrana Health's CEO?
Mr. Brandon K. Sim M.S. is the chief executive officer of Astrana Health Inc., which has about 3,000 employees.
Has ASTH ever split its stock?
Yes. The most recent ASTH stock split was a 1-for-10 split on Apr 27, 2015.
What is the ASTH 52-week high?
The 52-week high for ASTH is $51.60 and the 52-week low is $18.08. The stock is currently 44.0% below its high.